Design Defect Claims Against Generic Dilantin Makers Preempted, La. Federal Judge Rules

  • Order

NEW ORLEANS — A Louisiana federal judge has dismissed design defect claims brought against the makers of generic Dilantin, ruling they are federally preempted pursuant to Mutual Pharmaceutical Company Inc. v. Bartlett.

On Nov. 27, Judge Martin L.C. Feldman of the U.S. District Court for the Eastern District of Louisiana also granted Pfizer judgment on the pleadings because plaintiffs admitted that the decedent ingested only the drug’s generic version.

Jahmal and Jirus Tillman allege that their mother Rose Tillman died as a result of an adverse reaction to Dilation (phenytoin sodium).

According to the complaint, Tillman was taken to …

  • Austin & Associates
  • Baker Donelson Bearman Caldwell & Berkowitz
  • Barrasso Usdin Kupperman Freeman & Sarver
  • Greenberg Traurig
  • Hinshaw & Culbertson
  • Irwin Fritchie Urquhart & Moore
  • Jones Walker
  • Leake & Andersson
  • Pietragallo Gordon Alfano Bosick & Raspanti
  • Salley Hite Mercer & Resor


HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel


HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo